A project of the Kyushu University Medical Institute of Bioregulation supported by FFG Venture Partners has been selected by the Tokyo-based Japan Science and Technology Agency for its startup support program. The project aims to develop an analytical system that can be used to diagnose diseases and predict the side-effects of medications. Before establishing the company, Kyushu University will develop a system to streamline analysis and seek to reduce the time and cost involved. The Agency will fund the project for three years, providing up to ¥90 million in subsidies. The university aims to establish a startup company in or after fiscal 2022.